Integrated BioPharma, Inc.
INBP · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9,007 | $10,932 | $10,302 | $9,958 |
| - Cash | $4,732 | $3,615 | $2,961 | $2,461 |
| + Debt | $761 | $1,015 | $1,136 | $1,323 |
| Enterprise Value | $5,036 | $8,332 | $8,477 | $8,820 |
| Revenue | $0 | $14,175 | $13,947 | $12,614 |
| % Growth | -100% | 1.6% | 10.6% | – |
| Gross Profit | $1,019 | $1,469 | $1,551 | $1,171 |
| % Margin | – | 10.4% | 11.1% | 9.3% |
| EBITDA | $446 | $922 | $1,043 | $520 |
| % Margin | – | 6.5% | 7.5% | 4.1% |
| Net Income | $123 | -$178 | $611 | $116 |
| % Margin | – | -1.3% | 4.4% | 0.9% |
| EPS Diluted | 0.004 | -0.006 | 0.019 | 0.004 |
| % Growth | 167.2% | -129.9% | 424.3% | – |
| Operating Cash Flow | $1,301 | $591 | $616 | $201 |
| Capital Expenditures | -$173 | -$4 | -$116 | -$29 |
| Free Cash Flow | $1,128 | $587 | $500 | $172 |